Testimony Before the Ohio Senate Health Committee on SB 198 – Regarding The Federal 340B Drug Pricing Program
Testimony Before the Ohio Senate Health Committee on SB 198 Cameron Sholty, Executive Director, Heartland Impact November 12, 2025 Chairman Huffman, Members of the Committee: Thank you for the opportunity…








